Detalhe da pesquisa
1.
Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.
Malar J
; 16(1): 392, 2017 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28964258
2.
Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
Malar J
; 15(1): 519, 2016 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27769299
3.
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Antimicrob Agents Chemother
; 59(8): 4631-43, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26014942
4.
Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.
Malar J
; 14: 486, 2015 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626127
5.
Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
Malar J
; 12: 239, 2013 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23849006
6.
Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.
Malar J
; 11: 198, 2012 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22694953
7.
Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand.
Sci Rep
; 11(1): 13419, 2021 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34183715
8.
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Lancet Infect Dis
; 15(6): 683-91, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25877962